科学文献

我们与学术机构开展合作研究，以评估我们的管线产品。以下是发表的相关文献。

年：

Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma

T Martin, SZ Usmani, JM Schecter, M Vogel, CC Jackson, W Deraedt, H Tian, T Yeh, A Banerjee, L Pacaud, A Garrett, A Haltner, C Cameron, S Van Sanden, J Diels, S Valluri, IA Samjoo

Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review

Matthew Sussman, Concetta Crivera, Jennifer Benner & Nicholas Adair

Ciltacabtagene Autoleucel, a B-cell Maturation Antigen Directed Chimeric Antigen Receptor T-cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma (CARTITUDE-1): a phase 1b/2 open-label study

JG Berdeja, D Madduri, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, AK Stewart, P Hari, M Htut, A Lesokhin, A Deol, NC Munshi, E O’Donnell, D Avigan, I Singh, E Zudaire, TM Yeh, AJ Allred, Y Olyslager, A Banerjee, C Jackson, JD Goldberg, JM Schecter, W Deraedt, SH Zhuang, J Infante, D Geng, X Wu, MJ Carrasco-Alfonso, M Akram, F Hossain, S Rizvi, F Fan, Y Lin, T Martin, S Jagannath

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations

N Shah, M Sussman, C Crivera, S Valluri, J Benner, S Jagannath

Exploratory Trial of a Biepitopic CAR T-Targeting B Cell Maturation Antigen in Relapsed/Refractory Multiple Myeloma

J Xu, L-J Chen, S-S Yang, Y Sun, W Wu, Y-F Liu, J Xu, Y Zhuang, W Zhang, X-Q Weng, J Wu, Y Wang, J Wang, H Yan, W-B Xu, H Jiang, J Du, X-Y Ding, B Li, J-M Li, W-J Fu, J Zhu, L Zhu, Z Chen, F X-H Fan, J Hou, J-Y Li, J-Q Mi, S-J Chen